Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David W Cescon

Showing results (31-40 of 133) with videos related to

Pageof 14
Sort By:
Journal for Immunotherapy of Cancer|February 15, 2023
Changes in circulating tumor DNA and outcomes in solid tumors treated with immune checkpoint inhibitors: a systematic reviewLaith Al-Showbaki, Brooke Wilson, Faris Tamimi, et al.
Journal of Cancer|June 7, 2021
Network Meta-analysis Comparing Efficacy, Safety and Tolerability of Anti-PD-1/PD-L1 Antibodies in Solid CancersLaith Al-Showbaki, Michelle B Nadler, Alexandra Desnoyers, et al.
Journal of the National Cancer Institute|September 20, 2017
Toxicity of Extended Adjuvant Therapy With Aromatase Inhibitors in Early Breast Cancer: A Systematic Review and Meta-analysisHadar Goldvaser, Tristan A Barnes, Boštjan Šeruga, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2008
Invasive pulmonary aspergillosis associated with marijuana use in a man with colorectal cancerDavid W Cescon, Andrea V Page, Susan Richardson, et al.
Molecular Pharmaceutics|October 26, 2022
<sup>90</sup>Y-Labeled Gold Nanoparticle Depot (NPD) Combined with Anti-PD-L1 Antibodies Strongly Inhibits the Growth of 4T1 Tumors in Immunocompetent Mice and Induces an Abscopal Effect on a Distant Non-Irradiated TumorZhongli Cai, Rella Liu, Conrad Chan, et al.
Plos One|March 4, 2014
Extended adjuvant tamoxifen for early breast cancer: a meta-analysisMustafa Al-Mubarak, Ariadna Tibau, Arnoud J Templeton, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|October 22, 2008
Bowel loops and eyelid droopsJamie Spiegelman, David W Cescon, Yael Friedman, et al.
JNCI Cancer Spectrum|May 27, 2023
Utility of ctDNA in predicting relapse in solid tumors after curative therapy: a meta-analysisAbhenil Mittal, Consolacion Molto Valiente, Faris Tamimi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 6, 2015
NRF2 Pathway Activation and Adjuvant Chemotherapy Benefit in Lung Squamous Cell CarcinomaDavid W Cescon, Desmond She, Shingo Sakashita, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2024
Enhancing Early-Stage Breast Cancer Survivorship: Evidence-Based Strategies, Surveillance Testing, and Imaging GuidelinesMitchell J Elliott, Sherry Shen, Diana L Lam, et al.
Pageof 14

Showing results (31-40 of 133) with videos related to

Sort By:
Pageof 14
Journal for Immunotherapy of Cancer|February 15, 2023
Changes in circulating tumor DNA and outcomes in solid tumors treated with immune checkpoint inhibitors: a systematic reviewLaith Al-Showbaki, Brooke Wilson, Faris Tamimi, et al.
Journal of Cancer|June 7, 2021
Network Meta-analysis Comparing Efficacy, Safety and Tolerability of Anti-PD-1/PD-L1 Antibodies in Solid CancersLaith Al-Showbaki, Michelle B Nadler, Alexandra Desnoyers, et al.
Journal of the National Cancer Institute|September 20, 2017
Toxicity of Extended Adjuvant Therapy With Aromatase Inhibitors in Early Breast Cancer: A Systematic Review and Meta-analysisHadar Goldvaser, Tristan A Barnes, Boštjan Šeruga, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2008
Invasive pulmonary aspergillosis associated with marijuana use in a man with colorectal cancerDavid W Cescon, Andrea V Page, Susan Richardson, et al.
Molecular Pharmaceutics|October 26, 2022
<sup>90</sup>Y-Labeled Gold Nanoparticle Depot (NPD) Combined with Anti-PD-L1 Antibodies Strongly Inhibits the Growth of 4T1 Tumors in Immunocompetent Mice and Induces an Abscopal Effect on a Distant Non-Irradiated TumorZhongli Cai, Rella Liu, Conrad Chan, et al.
Plos One|March 4, 2014
Extended adjuvant tamoxifen for early breast cancer: a meta-analysisMustafa Al-Mubarak, Ariadna Tibau, Arnoud J Templeton, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|October 22, 2008
Bowel loops and eyelid droopsJamie Spiegelman, David W Cescon, Yael Friedman, et al.
JNCI Cancer Spectrum|May 27, 2023
Utility of ctDNA in predicting relapse in solid tumors after curative therapy: a meta-analysisAbhenil Mittal, Consolacion Molto Valiente, Faris Tamimi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 6, 2015
NRF2 Pathway Activation and Adjuvant Chemotherapy Benefit in Lung Squamous Cell CarcinomaDavid W Cescon, Desmond She, Shingo Sakashita, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2024
Enhancing Early-Stage Breast Cancer Survivorship: Evidence-Based Strategies, Surveillance Testing, and Imaging GuidelinesMitchell J Elliott, Sherry Shen, Diana L Lam, et al.
Pageof 14